Symposia: Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Antibody Therapy, clinical trials, Clinical Practice (Health Services and Quality), Translational Research, Plasma Cell Disorders, Combination therapy, Clinical Research, Diseases, Therapies, real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Monoclonal Antibody Therapy, Minimal Residual Disease , Transplantation, Vaccines
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Antibody Therapy, clinical trials, Clinical Practice (Health Services and Quality), Translational Research, Plasma Cell Disorders, Combination therapy, Clinical Research, Diseases, Therapies, real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Monoclonal Antibody Therapy, Minimal Residual Disease , Transplantation, Vaccines
Monday, December 12, 2022: 10:30 AM-12:00 PM
New Orleans Theater C
(Ernest N. Morial Convention Center)
Moderators:
Faith E Davies, MD, NYU Langone Health
and
Charlotte Pawlyn, PhD, ARRAY(0xf4739c0)
Disclosures:
Pawlyn: Abbvie: Consultancy; Sanofi: Consultancy, Honoraria; Janssen: Consultancy, Honoraria, Other: Travel support; Celgene/BMS: Consultancy, Honoraria.
A look at therapeutic impact of treatments and vaccines in certain populations of MM patients
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH